Phase I/II Trial of rBPI-21 (a Recombinant 21kD Fragment of Bactericidal/Permeability-Increasing Protein) in Children with Severe Meningococcemia.
Kirsch, E., Quint, P., Carroll, S., Scannon, P., Giroir, B.Volume:
7
Journal:
Shock
DOI:
10.1097/00024382-199703001-00577
Date:
March, 1997
File:
PDF, 110 KB
1997